• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

大剂量化疗和自体造血干细胞移植治疗老年原发性中枢神经系统淋巴瘤：一项初步研究。

High-dose chemotherapy and autologous stem cell transplant in elderly patients with primary CNS lymphoma: a pilot study.

机构信息

Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Department of Medical Oncology, University Hospital Basel & University of Basel, Basel, Switzerland.

出版信息

Blood Adv. 2020 Jul 28;4(14):3378-3381. doi: 10.1182/bloodadvances.2020002064.

DOI:10.1182/bloodadvances.2020002064
PMID:32722778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7391148/
Abstract

Age-adapted high-dose chemotherapy and autologous stem cell transplantation is safe and highly effective in elderly patients with PCNSL.

摘要

年龄调整的高剂量化疗和自体干细胞移植在老年 PCNSL 患者中是安全且高效的。

相似文献

1
High-dose chemotherapy and autologous stem cell transplant in elderly patients with primary CNS lymphoma: a pilot study.大剂量化疗和自体造血干细胞移植治疗老年原发性中枢神经系统淋巴瘤：一项初步研究。
Blood Adv. 2020 Jul 28;4(14):3378-3381. doi: 10.1182/bloodadvances.2020002064.
2
Putting caution in TEAM: high-dose chemotherapy with autologous HSCT for primary central nervous system lymphoma.在治疗原发性中枢神经系统淋巴瘤时谨慎采用TEAM方案：大剂量化疗联合自体造血干细胞移植。
Bone Marrow Transplant. 2012 Oct;47(10):1383-4. doi: 10.1038/bmt.2012.48. Epub 2012 Mar 19.
3
Parkinsonism as a late presentation of lymphomatosis cerebri following high-dose chemotherapy with autologous stem cell transplantation for primary central nervous system lymphoma.原发性中枢神经系统淋巴瘤患者接受大剂量化疗和自体干细胞移植后出现脑淋巴瘤继发的帕金森综合征。
J Neurol. 2020 Aug;267(8):2239-2244. doi: 10.1007/s00415-020-09819-y. Epub 2020 Apr 15.
4
Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphoma.非霍奇金淋巴瘤中枢神经系统累及患者采用噻替哌、白消安和环磷酰胺（TBC）预处理的自体干细胞移植。
Biol Blood Marrow Transplant. 2012 Jan;18(1):76-83. doi: 10.1016/j.bbmt.2011.07.006. Epub 2011 Jul 13.
5
High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial.高剂量化疗联合自体造血干细胞移植治疗新诊断的原发性中枢神经系统淋巴瘤：一项前瞻性、单臂、2期试验。
Lancet Haematol. 2016 Aug;3(8):e388-97. doi: 10.1016/S2352-3026(16)30050-3. Epub 2016 Jul 13.
6
Treatment of primary CNS lymphoma.原发性中枢神经系统淋巴瘤的治疗。
Blood. 2015 Feb 26;125(9):1360-1. doi: 10.1182/blood-2015-01-622498.
7
Primary central nervous system lymphoma: essential points in diagnosis and management.原发性中枢神经系统淋巴瘤：诊断与管理要点
Med Oncol. 2017 Apr;34(4):61. doi: 10.1007/s12032-017-0920-7. Epub 2017 Mar 17.
8
Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma.非霍奇金淋巴瘤中枢神经系统受累的诊断与治疗
Hematol Oncol Clin North Am. 2005 Aug;19(4):597-609, v. doi: 10.1016/j.hoc.2005.05.003.
9
High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma.非霍奇金淋巴瘤累及中枢神经系统患者的造血细胞移植大剂量疗法。
Biol Blood Marrow Transplant. 2000;6(3A):352-8. doi: 10.1016/s1083-8791(00)70060-7.
10
High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement.高剂量疗法及血液或骨髓移植治疗累及中枢神经系统的非霍奇金淋巴瘤
Biol Blood Marrow Transplant. 2005 Feb;11(2):93-100. doi: 10.1016/j.bbmt.2004.09.009.

引用本文的文献

1
Outcomes at a single institution with MTR induction and consolidation in the management of primary CNS lymphoma.单机构采用甲氨蝶呤诱导和巩固治疗原发性中枢神经系统淋巴瘤的疗效。
Blood Neoplasia. 2025 Apr 16;2(3):100102. doi: 10.1016/j.bneo.2025.100102. eCollection 2025 Aug.
2
Efficacy and safety of the thiotepa-busulfan conditioning regimen as for autologous stem cell transplantation in relapsed/refractory systemic diffuse large B cell lymphoma: a single-center retrospective study.硫替派-白消安预处理方案用于复发/难治性系统性弥漫大B细胞淋巴瘤自体干细胞移植的疗效和安全性：一项单中心回顾性研究
Int J Hematol. 2025 Jun;121(6):813-819. doi: 10.1007/s12185-025-03946-w. Epub 2025 Feb 12.
3
ICE polychemotherapy is an efficient salvage treatment in primary central nervous system lymphoma: an LOC network study.ICE多药联合化疗是原发性中枢神经系统淋巴瘤的一种有效挽救性治疗方法：一项LOC网络研究。
Blood Adv. 2025 Apr 22;9(8):1801-1804. doi: 10.1182/bloodadvances.2024014373.
4
High-dose chemotherapy with autologous haematopoietic stem cell transplantation in patients with isolated vitreoretinal lymphoma: a LOC network study.孤立性玻璃体视网膜淋巴瘤患者的大剂量化疗联合自体造血干细胞移植：一项LOC网络研究
Bone Marrow Transplant. 2025 Mar;60(3):297-304. doi: 10.1038/s41409-024-02477-y. Epub 2024 Nov 19.
5
Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.原发性中枢神经系统淋巴瘤：EHA-ESMO诊断、治疗及随访临床实践指南
Hemasphere. 2024 Jun 4;8(6):e89. doi: 10.1002/hem3.89. eCollection 2024 Jun.
6
Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101.原发中枢神经系统淋巴瘤的清髓性与非清髓性巩固治疗比较：Alliance 51101 研究结果
Blood Adv. 2024 Jun 25;8(12):3189-3199. doi: 10.1182/bloodadvances.2023011657.
7
Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study.利妥昔单抗-甲氨蝶呤、卡氮芥、替尼泊苷和泼尼松治疗原发性中枢神经系统淋巴瘤的生存、神经认知功能和健康相关生活质量结局：HOVON 105/ALLG NHL 24 研究的最终结果。
Neuro Oncol. 2024 Apr 5;26(4):724-734. doi: 10.1093/neuonc/noad224.
8
Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomas.基于 MRI 的 3D 肿瘤体积评估改善 CNS 淋巴瘤患者的早期预后预测。
Neuro Oncol. 2024 Feb 2;26(2):374-386. doi: 10.1093/neuonc/noad177.
9
Different patterns of failure in two treatment regimens for primary central nervous system lymphoma, a retrospective analysis of 124 cases in Taiwan.两种原发性中枢神经系统淋巴瘤治疗方案的失败模式不同：对台湾 124 例病例的回顾性分析。
Clin Exp Med. 2023 Dec;23(8):5327-5336. doi: 10.1007/s10238-023-01182-2. Epub 2023 Sep 7.
10
Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trial.年龄调整后的大剂量化疗后自体干细胞移植或 R-MP 作为一线治疗在老年原发性中枢神经系统淋巴瘤患者中的常规化疗 - 随机 III 期 PRIMA-CNS 试验。
BMC Cancer. 2023 Aug 18;23(1):767. doi: 10.1186/s12885-023-11193-7.

本文引用的文献

1
Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients.年龄调整的高剂量化疗和自体干细胞移植治疗老年和适合的原发性中枢神经系统淋巴瘤患者。
BMC Cancer. 2019 Mar 29;19(1):287. doi: 10.1186/s12885-019-5473-z.
2
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study.原发中枢神经系统淋巴瘤患者年龄 60 岁及以下时采用放疗或自体造血干细胞移植治疗的结果：ANOCEF-GOELAMS 多中心随机Ⅱ期 PRECIS 研究结果。
J Clin Oncol. 2019 Apr 1;37(10):823-833. doi: 10.1200/JCO.18.00306. Epub 2019 Feb 20.
3
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial.全脑放疗或自体干细胞移植作为原发性中枢神经系统淋巴瘤患者基于大剂量甲氨蝶呤的化疗免疫治疗后的巩固策略：国际结外淋巴瘤研究组-32二期试验第二次随机分组结果
Lancet Haematol. 2017 Nov;4(11):e510-e523. doi: 10.1016/S2352-3026(17)30174-6. Epub 2017 Oct 17.
4
High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study.大剂量噻替派为基础的化疗联合自体造血干细胞支持治疗老年原发性中枢神经系统淋巴瘤：一项欧洲回顾性研究。
Bone Marrow Transplant. 2017 Aug;52(8):1113-1119. doi: 10.1038/bmt.2017.23. Epub 2017 Apr 24.
5
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study).基于大剂量甲氨蝶呤的免疫化疗用于老年原发性中枢神经系统淋巴瘤患者（PRIMAIN研究）。
Leukemia. 2017 Apr;31(4):846-852. doi: 10.1038/leu.2016.334. Epub 2016 Nov 15.
6
High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial.高剂量化疗联合自体造血干细胞移植治疗新诊断的原发性中枢神经系统淋巴瘤：一项前瞻性、单臂、2期试验。
Lancet Haematol. 2016 Aug;3(8):e388-97. doi: 10.1016/S2352-3026(16)30050-3. Epub 2016 Jul 13.
7
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.甲氨蝶呤、阿糖胞苷、噻替派和利妥昔单抗联合化疗免疫疗法（MATRix方案）用于原发性中枢神经系统淋巴瘤患者：国际结外淋巴瘤研究组-32（IELSG32）2期试验首次随机分组结果
Lancet Haematol. 2016 May;3(5):e217-27. doi: 10.1016/S2352-3026(16)00036-3. Epub 2016 Apr 6.
8
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).高剂量化疗和自体干细胞移植与传统化疗用于新诊断的原发性中枢神经系统淋巴瘤巩固治疗的比较——一项随机III期试验（MATRix）
BMC Cancer. 2016 Apr 21;16:282. doi: 10.1186/s12885-016-2311-4.
9
Trends in primary central nervous system lymphoma incidence and survival in the U.S.美国原发性中枢神经系统淋巴瘤的发病率及生存率趋势
Br J Haematol. 2016 Aug;174(3):417-24. doi: 10.1111/bjh.14073. Epub 2016 Mar 28.
10
First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis.老年原发性中枢神经系统淋巴瘤（PCNSL）患者的一线治疗及预后——一项系统评价和个体患者数据荟萃分析
Ann Oncol. 2015 Jul;26(7):1305-13. doi: 10.1093/annonc/mdv076. Epub 2015 Feb 20.